1
H NMR (400 MHz, CD 2 Cl 2 ): δ = 13.88 (s, 1H), 9.48 (dd, J = 4.7, 1.6 Hz, 1H), 8.41 (dd, J = 8.3, 1.6 Hz, 1H), 8.37 (dd, J = 8.3, 1.6 Hz, 1H), 7.98 (dd, J = 5.2, 1.3 Hz, 1H), 7.92 (d, J = 8.9 Hz, 1H), 2H) , 7.67 (dd, J = 8.5, 1.0 Hz, 2H), 7.46 (t, J = 8.1 Hz, 2H), 7.33 (t, J = 7.3 Hz, 1H), 7.30 (dd, J = 8.2, 5.6 Hz, 1H), 6.91 (br s, 1H), 6.80 (t, J = 7.6 Hz, 1H), 6.71 (br s, 1H), 4.38 (br s, 1H), 3.13 (br s, 1H), 2.07 (s, 3H), 1.68 (s, 3H), 1.65 (s, 3H), 1.19 (br s, 6H), 0.85 (br s, 3H), 0.26 (s, 3H), -0.55 ppm (br s, 3H); 13 C NMR (100 MHz, CD 2 Cl 2 ): δ = 309. 6, 158.9, 150.5, 150.0, 149.6, 149.5, 145.8, 143.4, 139.3, 138.4, 138.0, 130.4, 129.9, 129.4, 128.7, 128.6, 127.9, 126.9, 126.7, 126.4, 126.3, 125.6, 125.1, 124.9, 80.1, 55.0, 32.0, 28.8, 28.2, 26.9, 26.6, 24.7, 24.3, 22.6, 21.5, 17.9, 17.6 ppm; 19 F NMR (377 MHz, CD 2 Cl 2 ): δ = -76.3 (q, J = 10.3 Hz, 3F), -77.4 (m, 3F), -77.6 (q, J = 10.3 Hz, 3F), -77.9 ppm (m, 3F); IR (film, cm -1 ): 2966, 2868, 1578, 1424, 1296, 1214, 1163, 1105, 1070, 958, 844, 762, 727, 697 (1, 316 mg, 413 μmol) in toluene (3 mL) was added to a solution of 2,2′-bipyridine (doubly sublimed, 65 mg, 413 μmol) in toluene (2 mL). After stirring for 1 h the precipitate was filtered off and washed with cold toluene (2 mL). The filtrate was concentrated and then cooled to -40°C to yield an additional crop of yellow crystals. The two crops were combined and dried in vacuo to give complex 3 as a yellow solid (354 mg, 93% 0, 159.7, 154.9, 153.1, 151.5, 150.3, 149.9, 149.7, 149.6, 148.0, 140.0, 139.2, 128.5, 126.8, 126.4, 126.3, 126.2, 122.8, 121.4, 80.1, 54.8, 31.9, 28.7, 28.5, 26.9, 26.1, 25.0, 24.5, 22.6, 17.7 ppm; 19 F NMR (377 MHz, CD 2 Cl 2 ): δ = -76.4 (q, J = 10.3 Hz, 3F), -77.1 (q, J = 10.3 Hz, 3F), -77.4 (m, 3F), -77.7 ppm (m, 3F); IR (film, cm -1 ): 2968, 2868, 1599, 1443, 1296, 1210, 1165, 1078, 1024, 955, 757, 697 H NMR, this complex is fully intact after storage on the bench in an open flask for eight weeks (decomposition < 5%) and shows no visible signs of decomposition either, see Figure S1 . H NMR spectra (CD 2 Cl 2 ) of the bipyridine adduct 3 (green), the original Schrock alkylidene 1 from which this adduct is derived (red), and the complex released in solution upon treatment of adduct 3 with ZnCl 2 in CD 2 Cl 2 at 100°C for 1h in a closed NMR tube (blue).
[Mo(CH-tBu)(NAr)(OSiPh 3 ) 2 (phen)] (Ar = 2,-6-diisopropylphenyl, 5a). A solution of Ph 3 SiOK (302 mg, 959 μmol) in toluene (5 mL) was added to a solution of [Mo(CH-tBu)(NAr)(OSO 2 CF 3 ) 2 (dme)] (350 mg, 480 μmol) in toluene (5 mL). After stirring for 1 h, the mixture was filtered and the filtrate added to a solution of 1,10-phenanthroline (doubly sublimed, 87 mg, 480 μmol) in toluene (5 mL). After stirring for 1 h and removal of the solvent, the residue was dissolved in the minimum amount of CH 2 Cl 2 (≤ 5 mL) and the product precipitated with pentane (25 mL). The precipitate was filtered off and dried in vacuo to give complex 5a as a yellow solid (417 mg, 81%). 9, 158.1, 150.2, 149.5, 145.0, 143.3, 141.4, 140.6, 138.6, 137.4, 136.7, 135.5, 135.3, 130.5, 130.1, 130.0, 128.5, 128.3, 128.0, 127.5, 127.4, 127.2, 127.0, 125.2, 124.9, 124.2, 123.1, 49.0, 32.0 ppm; IR (film, ): 2936, 2866, 1513, 1423, 1256, 1144, 1106, 1032, 947, 842, 760, 698 2, 157.5, 151.4, 150.2, 149.3, 144.6, 143.2, 141.4, 140.4, 138.3, 137.4, 136.7, 136.3, 135.4, 135.3, 130.5, 129.9, 129.8, 128.6, 128.3, 128.0, 127.8, 127.5, 127.4, 127.2, 127.0, 126.9, 126.1, 125.4, 124.5, 124.1, 54.6, 31.2, 28.3, 28.2, 22.6 ppm. IR (Film, ): 3065, 2963, 2866, 1517, 1426, 1333, 1285, 1110, 971, 918, 871, 742, 699 . 168.6, 162.2, 157.9, 154.4, 151.9, 151.6, 150.7, 150.4, 149.5, 148.8, 148.6, 146.9, 138.7, 138.4, 137.2, 133.8, 133.6, 133.2, 132.4, 132.0, 131.5, 129.2, 128.4, 127.2, 126.4, 125.7, 125.4, 125.3, 125.0, 124.9, 124.8, 122.6, 122.0, 121.2, 35.0, 34.8, 34.5, 32.1, 32.0, 31.5, 29.7, 27.4, 26.4, 25.2, 24.2, 22.6, 20.3, 20.1, 19.9, 16.4, 16.0, 15.8, 14.2 ppm; IR (film, ): 2920, 2862, 1738, 1595, 1408, 1261, 1040, 974, 859, 798, 756, 702 60. 5, 58.8, 41.2, 39.6, 14.3, 14.1; IR (neat, ): 2982 , 1730 , 1713 , 1641 , 1446 , 1368 , 1237 , 1180 , 1109 , 1065 , 1014 MS (EI) 124.7, 123.0, 61.3, 53.9, 36.6, 28.8, 28.1, 19.1, 18.9, 14.2; IR (neat, ): 2981, 2911, 1730, 1444, 1366, 1296, 1241, 1227, 1174, 1129, 1087, 1052, 1028, 861 1, 138.3, 131.1, 129.8, 128.7, 128.3, 128.1, 80.5, 79.1, 72.3, 64.0, 48.8, 47.5, 28.4 ): 3065, 3031, 2976 , 2927 , 2857 , 2108 , 1699 , 1657 , 1496 , 1456 , 1393 , 1366 , 1248 , 1168 , 1135 , 1095 MS (EI) H 7.02, N 16.27; found: C 62.72, H 6.94, N 16.19 . The analytical and spectroscopic data are in accordance with those reported in the literature. 2, 144.6, 128.5, 127.6, 127.3, 125.7, 73.5, 39.1, 0.0, IR (film, ): 2958 , 2855 , 1587 , 1249 , 1062 MS (EI) 9, 155.1, 137.4, 129.1, 128.8, 126.9, 123.6, 122.7, 120.5, 111.1, 103.5, 35.1 ppm; IR (film, ): 3029, 2906 , 1738 , 1585 , 1495 , 1453 , 1251 , 1163 MS (EI) A solution containing complex 7 (12 mg, 13 μmol, 5 mol%) and anhydrous ZnCl 2 (1.8 mg, 13 μmol) in toluene (1 mL) was stirred at 65°C for 1 h. After this activation phase, the mixture was allowed to reach ambient temperature before a solution of (6E)-6-methyl-5-tert-butyldimethylsiloxy-1,6-octadiene (55 mg, 216 μmol) in toluene (1.2 mL) was introduced. The flask was sealed and stirring continued for 60 min before the reaction was stopped by the addition of MeOH (1 mL). All volatile materials were evaporated and the ring-closed product and unreacted starting material were separated by flash chromatography (hexanes).
(6E)-6-Methyl-5-tert-butyldimethylsiloxy-1,6-octadiene. Colorless oil (18 mg, 27%), ee = 99% (determined by GC using a chiral stationary phase: Ivadex-1/PS086 (dimethyl-pentyl-ß-cyclodextrine, 25 m)); 1, 138.4, 119.8, 114.3, 78.2, 35.7, 30.3, 26.0, 18.4, 13.1, 10.9, IR (film, ): 2929 , 2858 , 1738 , 1641 , 1472 , 1361 , 1252 , 1217 , 1071 MS (EI) 2-Methyl-1-tert-butyldimethylsiloxy-2-cyclopentene. Colorless oil (18 mg, 33%), ee = 70% (determined by GC using a chiral stationary phase: BGB-176/SE-52 (2,3-dimethyl-6-tertbutyldimethylsilyl-ß-cyclodextrine, 30 m)); 2, 126.9, 80.3, 34.5, 29.8, 26.1, 14.0, IR (film, ): 2930 , 2856 , 1462 , 1354 , 1249 , 1080 MS (EI) 
Desymmetrization.
A solution of complex 7 (7 mg, 7 μmol, 5 mol%) and anhydrous ZnCl 2 (1.0 mg, 7 μmol) in toluene (0.5 mL) was stirred at 80°C for 30 min. After this activation phase, the mixture was allowed to reach ambient temperature before a solution of 3-allyl-(2,4-dimethyl-1,4-pentadienyl) ether (22 mg, 145 μmol) in toluene (1.0 mL) was introduced. Stirring was continued for 6 h before the solvent was evaporated and the residue purified by flash chromatography (pentanes/ether, 9:1) to afford pure 2-iso-propenyl-3-methyl-2,5-dihydrofuran (15 mg, 85%, 90% ee) as a colorless liquid. 8, 137.4, 122.0, 113.4, 93.3, 76.0, 15.9, 12.2; IR (neat, ): 2849 , 1604 , 1495 , 1450 , 1184 , 1067 MS (EI) 
